IMAC Holdings, Inc., Announces Dr. Ben Lerner as Chief Operating Officer
IMAC Holdings, Inc. (Nasdaq: IMAC) has appointed Dr. Ben Lerner as Chief Operating Officer, effective February 21, 2022. Dr. Lerner brings over 20 years of healthcare and business experience, previously founding Maximized Living and leading multiple successful ventures. IMAC specializes in innovative orthopedic treatments and operates numerous outpatient clinics. The addition of Dr. Lerner is anticipated to enhance IMAC's leadership team and support its growth objectives. IMAC currently conducts clinical research for a stem cell therapy aimed at Parkinson's disease.
- Appointment of Dr. Ben Lerner as COO expected to strengthen leadership.
- Dr. Lerner has extensive experience in healthcare and business development.
- IMAC operates in the growing sector of regenerative and rehabilitative medicine.
- Clinical trial for stem cell therapy could lead to significant advancements.
- No immediate financial data or metrics were disclosed to assess impact.
- -
Dr. Lerner, a New York Times best-selling author and holistic health and business expert,
brings healthcare growth experience to IMAC executive team.
BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, announces the addition of healthcare veteran Dr. Ben Lerner to the position of Chief Operating Officer. Dr. Matt Wallis, a founder of IMAC and current COO, will continue as President and Executive Director of the Company upon Dr. Lerner’s addition February 21st.
Previously, Dr. Lerner was founder of Maximized Living, a national chiropractic consulting, franchising, and lifestyle brand organization. As CEO, he managed five interconnected companies, consulted for thousands of doctors and chiropractic students, opened more than 100 franchises, created 500 licensees, and built and sustained a large supplement and spinal rehab equipment manufacturing business.
“The entire team is excited to welcome Dr. Lerner to IMAC Holdings,” said Jeff Ervin, Chief Executive Officer. “He has an incredible combination of health and business knowledge that he has earned with successful past ventures. We believe his experience correlates well with IMAC’s vision and strengthens our leadership team to achieve the next phase of the Company’s growth objectives. Dr. Lerner is a great fit for IMAC.”
Dr. Lerner, who holds a bachelor’s degree in nutrition and a master’s degree in industrial and organizational psychology, is a Doctor of Chiropractic, and is completing a doctorate in business administration. He boasts 20 years of experience as a C-Suite executive and healthcare startup leader. After selling Maximized Living in January 2017, he founded the Ultimate Impact Group, a healthcare startup consisting of an amalgamation of several different companies, drawing upon his 25 years of experience in business, franchising, health care, real estate and product manufacturing.
In addition, he previously served as the chiropractor and wellness advisor for the U.S. World Wrestling, Weightlifting, and Judo teams at multiple World Championships and Olympic Games. Lerner is a two-time New York Times best-selling author who has written more than 20 books. He has served as the chairman of global wellness for the Billion Soul Initiative, where his health curriculum has been translated into dozens of languages.
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, The Back Space, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk to promote a minimally invasive approach to sports medicine. IMAC’s The Back Space retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC’s research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. For more information visit www.imacholdings.com.
###
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
IMAC Press Contact:
Laura Fristoe
lfristoe@imacrc.com
FAQ
Who is Dr. Ben Lerner in relation to IMAC Holdings?
What experience does Dr. Lerner bring to IMAC Holdings?
What is IMAC Holdings known for?
What clinical research is IMAC currently conducting?
What impact could Dr. Lerner's appointment have on IMAC's growth?
